198 related articles for article (PubMed ID: 27544928)
1. Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody.
Michot JM; Mazeron R; Dercle L; Ammari S; Canova C; Marabelle A; Rose S; Rubin E; Deutsch E; Soria JC; Ribrag V; Levy A
Eur J Cancer; 2016 Oct; 66():91-4. PubMed ID: 27544928
[No Abstract] [Full Text] [Related]
2. Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too.
Canales MA; Martin A; Caballero D; Hernandez-Navarro F
Br J Haematol; 2006 Sep; 134(6):645-6. PubMed ID: 16889614
[No Abstract] [Full Text] [Related]
3. Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma.
Anderson CC; Goldstone AH; Souhami RL; Linch DC; Harper PG; McLennan KA; Jones M; Machin SJ; Jelliffe AM; Cawley JC
Cancer Chemother Pharmacol; 1986; 16(2):170-5. PubMed ID: 3512114
[TBL] [Abstract][Full Text] [Related]
4. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
5. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.
Colwill R; Crump M; Couture F; Danish R; Stewart AK; Sutton DM; Scott JG; Sutcliffe SB; Brandwein JM; Keating A
J Clin Oncol; 1995 Feb; 13(2):396-402. PubMed ID: 7844600
[TBL] [Abstract][Full Text] [Related]
6. Pembrolizumab for classical Hodgkin's lymphoma.
Burki TK
Lancet Oncol; 2016 Aug; 17(8):e324. PubMed ID: 27397043
[No Abstract] [Full Text] [Related]
7. A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.
Østby I; Rusten LS; Kvalheim G; Grøttum P
J Math Biol; 2003 Aug; 47(2):101-36. PubMed ID: 12883857
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
9. Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.
Vitolo U; Barosi G; Fanti S; Gianni AM; Martelli M; Petrini M; Zinzani PL; Tura S
Am J Hematol; 2010 Feb; 85(2):147-55. PubMed ID: 20095035
[No Abstract] [Full Text] [Related]
10. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
[TBL] [Abstract][Full Text] [Related]
11. [Autologous transplant with BEAM protocol in lymphoma].
Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
[No Abstract] [Full Text] [Related]
12. Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma.
Lee JJ; Chan A; Tang T
Acta Oncol; 2016; 55(4):519-20. PubMed ID: 26754959
[No Abstract] [Full Text] [Related]
13. Low-dose pembrolizumab induced complete radiologic and molecular response of posttransplant lymphoproliferative disorder presenting as classical Hodgkin lymphoma.
Sim JPY; Au-Yeung R; Kwong YL
Ann Hematol; 2020 Feb; 99(2):385-388. PubMed ID: 31773213
[No Abstract] [Full Text] [Related]
14. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.
Schmitz N; Pfistner B; Sextro M; Sieber M; Carella AM; Haenel M; Boissevain F; Zschaber R; Müller P; Kirchner H; Lohri A; Decker S; Koch B; Hasenclever D; Goldstone AH; Diehl V; ;
Lancet; 2002 Jun; 359(9323):2065-71. PubMed ID: 12086759
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
Krishnan A; Nademanee A; Fung HC; Raubitschek AA; Molina A; Yamauchi D; Rodriguez R; Spielberger RT; Falk P; Palmer JM; Forman SJ
J Clin Oncol; 2008 Jan; 26(1):90-5. PubMed ID: 18025438
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Clavio M; Garrone A; Pierri I; Michelis GL; Balocco M; Albarello A; Varaldo R; Canepa P; Miglino M; Ballerini F; Canepa L; Gobbi M
Oncol Rep; 2005 Oct; 14(4):933-40. PubMed ID: 16142354
[TBL] [Abstract][Full Text] [Related]
17. Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.
Milojković D; Aldouri M; Pagliuca A; Mufti GJ; Devereux S
Bone Marrow Transplant; 2006 Sep; 38(6):461-2. PubMed ID: 16951694
[No Abstract] [Full Text] [Related]
18. Low-dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma.
Kwong YL; Lopes D; Khong PL
Br J Haematol; 2017 Jan; 176(1):131-132. PubMed ID: 26773814
[No Abstract] [Full Text] [Related]
19. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
Torjman L; Ladeb S; Lakhal A; Ben Othman T; Abdelkefi A; Ben Abdeladhim A
Tunis Med; 2007 Jan; 85(1):35-8. PubMed ID: 17424707
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone ("Yasmine").
Tartarone A; Gallucci G; Cammarota A; Romano G; Ardito R; Di Renzo N
Bone Marrow Transplant; 2005 Jan; 35(1):103. PubMed ID: 15531905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
